PreciseDx
PrivateLast Round
Series B
Extension
Jun 18, 2025
Total Funding Raised
$53.2M
Company Overview
PreciseDx is a healthcare technology company that specializes in artificial intelligence-driven pathology diagnostics aimed at enhancing patient outcomes in cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Healthcare Analytics, Medical Imaging
Business Model
B2B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreciseDx Comparables
Compare PreciseDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StratifAI GmbH | 84% | |
| ArteraAI | 83% | |
| Valar Labs | 82% | |
PreciseDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 18, 2025 | ||||
| Series B | Aug 21, 2024 | ||||
| Series A | Jan 11, 2022 |
Key People
Founding team and executive leadership
PreciseDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Series B Extension, Series B |
| Philips Ventures | Series B Extension |
| Eventide Funds | Series B Extension, Series B |
| IBM Ventures | Series A |
| Hobart Healthcare | Series A |
PreciseDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PreciseDx's valuation, stock price, and market status.